Detalhe da pesquisa
1.
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
N Engl J Med
; 384(2): 105-116, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33185990
2.
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF.
J Card Fail
; 30(1): 26-35, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683911
3.
Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart Failure.
J Card Fail
; 29(6): 896-906, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632934
4.
Effects of Serelaxin in Patients with Acute Heart Failure.
N Engl J Med
; 381(8): 716-726, 2019 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433919
5.
Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches.
Heart Fail Rev
; 26(1): 11-21, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32783110
6.
Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial.
Lancet
; 388(10062): 2895-2903, 2016 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27914656
7.
Blood pressure reactivity to psychological stress is associated with clinical outcomes in patients with heart failure.
Am Heart J
; 191: 82-90, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28888274
8.
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
JAMA
; 318(8): 713-720, 2017 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28829876
9.
Reactive hyperemia is associated with adverse clinical outcomes in heart failure.
Am Heart J
; 178: 108-14, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502858
10.
Improving cardiovascular clinical trials conduct in the United States: recommendation from clinicians, researchers, sponsors, and regulators.
Am Heart J
; 169(3): 305-14, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25728719
11.
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
Lancet
; 381(9860): 29-39, 2013 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23141816
12.
The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure.
Am Heart J
; 167(2): 193-202.e1, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24439980
13.
Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION.
J Card Fail
; 20(1): 38-44, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24304938
14.
Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions.
Heart Fail Rev
; 19(2): 135-52, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23099992
15.
Galectin-3: a modifiable risk factor in heart failure.
Cardiovasc Drugs Ther
; 28(3): 237-46, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24789662
16.
Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients.
Heart Fail Clin
; 10(4): 607-20, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25217436
17.
Depressive symptoms are associated with clinical outcomes in heart failure with reduced ejection fraction.
ESC Heart Fail
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38715254
18.
Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure.
J Am Coll Cardiol
; 83(14): 1295-1306, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569758
19.
Biomarker-guided therapies in heart failure: a forum for unified strategies.
J Card Fail
; 19(8): 592-9, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23910590
20.
Use of patient-reported outcomes in heart failure: from clinical trials to routine practice.
Eur J Heart Fail
; 25(2): 139-151, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36644876